Interferon alfa-2b biosimilar (BioGeneric)

干扰素α-2b生物类似药 (BioGeneric)

Report date: 2022/01/24 09:34:25

Base Information

Drug NameInterferon alfa-2b biosimilar (BioGeneric)
Drug Alias Name干扰素α-2b生物仿制药 (BioGeneric)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B
Global Approved IndicationsNeoplasmsHepatitis CHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEgypt
Original Approved Date2013/05/01
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiogeneric Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBiogeneric Pharma
Inactive CompaniesN/A
Active IndicationsNeoplasmsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A